282 related articles for article (PubMed ID: 15140570)
1. Involvement of CTLA-4 in T-cell anergy induced by staphylococcal enterotoxin A in vitro.
Xu GL; Zhu XH; Guo B; Wu YZ
Mol Immunol; 2004 May; 41(1):1-8. PubMed ID: 15140570
[TBL] [Abstract][Full Text] [Related]
2. Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration.
Schols D; Jones D; Roncarolo MG
J Immunol; 1995 Apr; 154(7):3204-12. PubMed ID: 7534791
[TBL] [Abstract][Full Text] [Related]
3. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
Zhou T; Weaver C; Linsley PS; Mountz JD
Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
[TBL] [Abstract][Full Text] [Related]
4. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.
Soares LR; Rivas A; Ruegg C; Engleman EG
Eur J Immunol; 1997 Jun; 27(6):1413-21. PubMed ID: 9209493
[TBL] [Abstract][Full Text] [Related]
5. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
6. Induction of responsiveness in superantigen-induced anergic T cells. Role of ligand density and costimulatory signals.
Heeg K; Wagner H
J Immunol; 1995 Jul; 155(1):83-92. PubMed ID: 7602125
[TBL] [Abstract][Full Text] [Related]
7. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
Lane P; Haller C; McConnell F
Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
[TBL] [Abstract][Full Text] [Related]
8. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
9. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship.
Miethke T; Wahl C; Gaus H; Heeg K; Wagner H
Eur J Immunol; 1994 Aug; 24(8):1893-902. PubMed ID: 8056049
[TBL] [Abstract][Full Text] [Related]
10. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes.
Corrigall VM; Solau-Gervais E; Panayi GS
Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766
[TBL] [Abstract][Full Text] [Related]
11. Induction of clonal anergy by oral administration of staphylococcal enterotoxin B.
Migita K; Ochi A
Eur J Immunol; 1994 Sep; 24(9):2081-6. PubMed ID: 8088329
[TBL] [Abstract][Full Text] [Related]
12. Requirements for stimulation or anergy induction in alloreactive human T cell clones.
Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D
Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CD28 expression on CD8+ T cells by CTLA-4.
Berg M; Zavazava N
J Leukoc Biol; 2008 Apr; 83(4):853-63. PubMed ID: 18162511
[TBL] [Abstract][Full Text] [Related]
14. B7-blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells.
Yi-qun Z; Lorré K; de Boer M; Ceuppens JL
J Immunol; 1997 May; 158(10):4734-40. PubMed ID: 9144487
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
[TBL] [Abstract][Full Text] [Related]
16. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
[TBL] [Abstract][Full Text] [Related]
17. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2, but not interleukin-15, is required to terminate experimentally induced clonal T-cell anergy.
Bendiksen S; Rekvig OP
Scand J Immunol; 2004; 60(1-2):64-73. PubMed ID: 15238074
[TBL] [Abstract][Full Text] [Related]
19. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.
Lando PA; Dohlsten M; Hedlund G; Brodin T; Sansom D; Kalland T
Immunology; 1993 Oct; 80(2):236-41. PubMed ID: 7505257
[TBL] [Abstract][Full Text] [Related]
20. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]